Corporate Banner
Satellite Banner
Proteomics
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Alim-Louis Benabid Honored by U.S. Research Institute

Published: Friday, October 11, 2013
Last Updated: Friday, October 11, 2013
Bookmark and Share
Benabid has received the Jay Van Andel Award for Outstanding Achievement in Parkinson’s Disease Research.

CEA-Leti has announced that Prof. Alim-Louis Benabid, chairman of CLINATEC, has been honored by a second major U.S. Parkinson’s disease (PD) organization for his work in treating PD.

Benabid received the Jay Van Andel Award for Outstanding Achievement in Parkinson’s Disease Research at Van Andel Institute’s Grand Challenges in Parkinson’s Disease Symposium in September.

The award recognizes his invention of deep brain stimulation (DBS), a highly specialized method used to treat specific kinds of neurological diseases, including Parkinson’s disease.

“Dr. Benabid has made an incredible contribution to the treatment of Parkinson's disease by developing deep brain stimulation,” said Patrik Brundin, director of the Van Andel Institute’s Center for Neurodegenerative Science.

Brundin continued, “Today over 140,000 advanced Parkinson’s patients have undergone DBS treatment, which essentially changes the ‘electric connections’ in the brain, and they are able to move remarkably much better thanks to Dr. Benabid's invention.”

Benabid, who has received many honors during his career, was awarded the 2013 Robert H. Pritzker Prize for Leadership in Parkinson’s Research from the Michael J. Fox Foundation earlier this year.

“The Van Andel Institute’s research program has a powerful impact on biomedical research in cancer and Parkinson’s disease, with an emphasis on translating scientific research results into clinical applications,” Benabid said. “I am honored to receive this award, and I’m proud to highlight the CLINATEC team’s ongoing work on infrared brain stimulation to improve treatment of PD, and perhaps severe depression, Alzheimer’s disease, Tourette’s syndrome and other neurological conditions.”

Benabid helped found CLINATEC, the multidisciplinary biomedical research center created by Leti, Grenoble University Hospital, INSERM and Joseph Fourier University in 2009.

The center allows medical practitioners, researchers, biologists, and technologists to collaborate on the frontier of health care and micro- and nanoelectronics.

Using a unique biomedical and surgery platform, CLINATEC’s main objective is to accelerate and make safer the translation of technological innovation for treating patients.

Benabid has centered his scientific activity on the approach of neurosurgical pathologies, particularly brain tumors and movement disorders.

From 1989 to 2007, he was head of the Neurosurgery Department at the University Hospital of Grenoble. He currently is a professor emeritus of biophysics at Joseph Fourier University.


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,200+ scientific posters on ePosters
  • More than 4,800+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.


Scientific News
Liquid Biopsies: Miracle Diagnostic or Next New Fad?
Thanks to the development of highly specific gene-amplification and sequencing technologies liquid biopsies access more biomarkers relevant to more cancers than ever before.
Cell Cargo Ships in Near Future?
Virus-inspired container design may lead to cell cargo ships following construction of ten large, two-component, icosahedral protein complexes.
Protein Reinforces Growth of Damaged Muscles
Biologists have found a protein involved in stem cells that bolsters damaged muscle tissue growth - potential for muscle degeneration treatments.
Structure of Cold Virus Solved
Researchers have identified the structure of an elusive cold virus linked to child asthma and respiratory infections, providing the foundation for treating the virus.
New Protein Model Could Accelerate Drug Development
Stony Brook-led international research team creates ultra-fast approach to model protein interactions.
Researchers Can Control Genes Involved in Cancer
A new way to control the activity of a protein, that is often upregulated in cancer, has been discovered by Moffitt researchers through monoubiquitination mechanism.
Mitochondrial Role in Metastatic Cancer
Researchers have manipulated proteins, sourced from tumour cells, that are essential for maintaining tumour cells and in doing so, have significantly reduced the ability of cancer cells.
Liquid Biopsy Predicts Colon Cancer Recurrence
Scientists have used a genetic test that spots bits of cancer-related DNA circulating in the blood to accurately predict the likelihood of the disease’s return in some — but not all — of a small group of patients with early-stage colon cancer.
Scientists Culture Elusive Yellowstone Microbe
ORNL scientists have successfully isolated and cultured a Yellowstone sourced acidic hot-spring based microbe.
Seeing RNA at the Nanoscale
MIT researchers have developed a new way to image proteins and RNA inside neurons of brain tissue.
Scroll Up
Scroll Down
SELECTBIO

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,200+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,800+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!